Come up with a name for your new list and we'll add to it:
Thermalin Diabetes raised a round of funding on July 30, 2014. Investors include
Cleveland Economic Development.
Thermalin is pursuing promising product profiles that will improve insulin therapy for specific classes of patients and enable new delivery technologies. These include: Ultra-concentrated (U500) insul…